Table 5.
Indicator | No. (for 3 years) | Rate of utilization (for 3 years) (%) | Payer |
---|---|---|---|
Hospitalizations by reason | No. of hospitalizations | ||
Hospitalizations due to decompensated liver disease/cirrhosis | 487 | 59 | NHIF |
Hospitalizations due to diseases of the hepatobiliary system, pancreas, and peritoneum | 230 | 28 | NHIF |
Hospitalizations due to endoscopic variceal ligation | 109 | 13 | NHIF |
Medicines | No. of patients | ||
Ceftriaxone | 120 | 41 | Hospital |
Ciprofloxacin | 111 | 38 | Hospital |
Terlipressin | 12 | 4 | Hospital |
Esomeprazole | 122 | 41 | Hospital |
Albumin | 131 | 44 | Patients |
Spironolactone + furosemide | 113 | 38 | Patients |
Propranolol/carvedilol | 143 | 48 | Patients |
Norfloxacin | 30 | 10 | Patients |
Bands for endoscopic treatment | 45 | 15 | Patients |
l-Ornitine-l-aspartate | 42 | 15 | Patients |
Contrast material | 60 | 20 | Patients |